Inspiratory Muscle Training for Breast Cancer Survivors with Obesity
(IMOCS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a breathing exercise program can improve fitness levels in breast cancer survivors dealing with obesity. Participants will be divided into two groups: one will perform a specific breathing exercise called inspiratory muscle training, while the other will engage in a similar but less intense version. Both groups will also participate in aerobic exercises like walking or cycling. This trial suits breast cancer survivors who have completed treatment, have a BMI between 30 and 50, and find it challenging to be active. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative research that could enhance the quality of life for breast cancer survivors.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it does allow participants who are on adjuvant endocrine therapy to join.
What prior data suggests that inspiratory muscle training is safe for breast cancer survivors with obesity?
Research has shown that inspiratory muscle training (IMT) is generally safe for breast cancer survivors, including those who are overweight. Studies have found that this training improves breathing and participants tolerate it well. No major reports of harmful side effects have emerged from using IMT in these groups.
Exercise training, often part of recovery for cancer survivors, is also considered safe. Research indicates that exercise improves physical abilities and reduces fatigue. Cancer survivors tolerate it well, and it is often recommended to enhance overall health and quality of life.
In summary, both inspiratory muscle training and exercise training are safe and beneficial for breast cancer survivors. Research supports their use without major safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about inspiratory muscle training (IMT) for breast cancer survivors with obesity because it targets respiratory muscles directly, unlike traditional options like general aerobic exercise or weight management programs. IMT uses a pressure threshold device to enhance lung strength and endurance, which can potentially improve overall fitness and quality of life for survivors. This approach is particularly promising because it addresses specific physical challenges faced by survivors, such as fatigue and reduced exercise capacity, in a way that standard exercise routines might not.
What evidence suggests that inspiratory muscle training is effective for improving exercise tolerance in obese breast cancer survivors?
Research has shown that inspiratory muscle training (IMT), which participants in this trial may receive, strengthens the muscles used for breathing and improves fitness in cancer survivors. Studies also find that IMT reduces symptoms like stress and tiredness and boosts physical ability, especially in those who are overweight. Exercise training, included in both treatment arms of this trial, enhances physical performance and reduces fatigue in breast cancer survivors. It also improves quality of life by boosting physical function and overall well-being. Together, IMT and exercise training might help breast cancer survivors who are overweight improve their exercise capacity.13456
Who Is on the Research Team?
Dharini M Bhammar, PhD
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for sedentary obese breast cancer survivors with a BMI of 30-50, who finished treatment for Stage 0-III cancer within the past 6 months to 5 years. Participants should have some exercise intolerance but can't join if they smoke, are pregnant/nursing, or have heart disease, severe joint issues, recent infections treated with antibiotics or steroids, or any psychiatric conditions that affect study compliance.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Inspiratory Muscle Training (IMT) or SHAM
Participants undergo 4 weeks of either IMT or SHAM training, 3 times per week, with specific intensity levels using a pressure threshold device
Exercise Training
Participants engage in 12 weeks of aerobic exercise training including cycling, walking, and elliptical, starting in week 5, 3 times per week, up to 50 minutes per session at moderate intensity
Follow-up
Participants are monitored for changes in dyspnea, fatigue, exercise capacity, and inspiratory muscle strength and endurance
What Are the Treatments Tested in This Trial?
Interventions
- Exercise training
- Inspiratory muscle training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Lead Sponsor